Class of drug | Indication | Contraindications | |||||
---|---|---|---|---|---|---|---|
Compelling | Possible | Possible | Compelling | ||||
α Blockers | Prostatism | Dyslipidaemia | Postural hypotension | Urinary incontinence | |||
ACE inhibitors | Heart failure, left ventricular dysfunction, type 1 diabetic nephropathy | Chronic renal disease1-150, type 2 diabetic nephropathy | Renal impairment1-150, peripheral vascular disease1-151 | Pregnancy, renovascular disease | |||
Angiotensin II receptor antagonists | Cough induced by ACE inhibitor1-152 | Heart failure, intolerance of other antihypertensive drugs | Peripheral vascular disease1-151 | Pregnancy, renovascular disease | |||
β Blockers | Myocardial infarction, angina | Heart failure1-153 | Heart failure1-153, dyslipidaemia, peripheral vascular disease | Asthma or chronic obstructive pulmonary disease, heart block | |||
Calcium antagonists (dihydropyridine) | Isolated systolic hypertension in elderly patients | Angina, elderly patients | – | – | |||
Calcium antagonists (rate limiting) | Angina | Myocardial infarction | Combination with β blockade | Heart block, heart failure | |||
Thiazides | Elderly patients | – | Dyslipidaemia | Gout |
↵1-150 Angiotensin converting enzyme (ACE) inhibitors may be beneficial in chronic renal failure but should be used with caution. Close supervision and specialist advice are needed when there is established and significant renal impairment.
↵1-151 Caution with ACE inhibitors and angiotensin II receptor antagonists in peripheral vascular disease because of association with renovascular disease.
↵1-152 If ACE inhibitor indicated.
↵1-153 β Blockers may worsen heart failure, but in specialist hands by be used to treat heart failure.